1. Home
  2. HIO vs ARMP Comparison

HIO vs ARMP Comparison

Compare HIO & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset High Income Opportunity Fund Inc.

HIO

Western Asset High Income Opportunity Fund Inc.

HOLD

Current Price

$3.62

Market Cap

348.1M

Sector

Finance

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$5.10

Market Cap

295.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIO
ARMP
Founded
1993
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
348.1M
295.5M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
HIO
ARMP
Price
$3.62
$5.10
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
331.0K
192.0K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
10.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.52
$2.14
52 Week High
$4.05
$14.98

Technical Indicators

Market Signals
Indicator
HIO
ARMP
Relative Strength Index (RSI) 51.42 30.23
Support Level $3.63 $4.96
Resistance Level $3.68 $7.67
Average True Range (ATR) 0.03 0.67
MACD 0.00 -0.12
Stochastic Oscillator 52.17 4.96

Price Performance

Historical Comparison
HIO
ARMP

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: